| Category | Disease/Syndrome | Analysis Method | Fish Probes or Gene Mutation * analysed by contract laboratory | Accreditation |
|---|---|---|---|---|
| Tumor cytogenetics | Acute lymphoblastic leukemia (ALL) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Acute lymphoblastic leukemia (ALL) | optional FISH | BCR/ABL t(9;22) | + |
| Tumor cytogenetics | Acute lymphoblastic leukemia (ALL) | optional FISH | c-myc (8q24) | + |
| Tumor cytogenetics | Acute lymphoblastic leukemia (ALL) | optional FISH | MLL (11q23) | + |
| Tumor cytogenetics | Acute lymphoblastic leukemia (ALL) | optional FISH | ETV6 (12p13) | + |
| Tumor cytogenetics | Acute lymphoblastic leukemia (ALL) | optional FISH | P16 (9p21) | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | EVI1 3q26 | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | EGR1 5q31 | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | D7S522 7q31 | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | CEP8 (Zentromer 8) | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | RUNX1/RUNX1T1 [AML1/ETO] t(8;21) | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | MLL (11q23) | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | PML/RARA t(15;17) | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | optional FISH | CBFB inv/t(16q22) | + |
| Tumor cytogenetics | Acute myeloid leukemia (AML) | NGS | AML-Panel (ASXL1; CBL; CEBPA; CSF3R; DNMT3A; IDH1; IDH2; KIT; KRAS; MLL; NPM1; NRAS; PTPN11; RUNX1; TET2; TP53; WT1 ) | - |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | FISH | MYB (6q23) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | FISH | ATM (11q22.3) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | FISH | CEP12 (Zentromer 12) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | FISH | D13S319 (13q14)/LAMP1 (13q34) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | FISH | IGH (14q32) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | FISH | TP53 (17p13) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | optional FISH | CCND1/IGH t(11;14) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | optional FISH | IGH/BCL2 t(14;18) | + |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | molecular genetics | IGvH | - |
| Tumor cytogenetics | Chronic lymphocytic leukämia (CLL) | molecular genetics | TP53 | - |
| Tumor cytogenetics | Chronic myeloid Leukemia (CML) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Chronic myeloid Leukemia (CML) | optional FISH | BCR/ABL t(9;22) qualitativ | + |
| Tumor cytogenetics | Chronic myeloid Leukemia (CML) | optional molecular genetics | BCR/ABL quantitativ * | - |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | optional FISH | TET2 (4q24) | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | optional FISH | EGR1 (5q31) | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | optional FISH | D7S522 (7q31) | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | optional FISH | CEP8 (Zentromer 8) | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | optional FISH | TP53 (17p13) | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | optional FISH | PTPRT MYBL (20q12) | + |
| Tumor cytogenetics | Myelodysplastic syndrome (MDS) | NGS | MDS-Panel (ASXL1; CBL; DNMT3A; ETV6/TEL; EZH2; IDH1; IDH2; RUNX1; SF3B1; SRSF2; TET2; TP53; U2AF1; WT1; ZRSR2) | - |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | optional FISH | BCR/ABL t(9;22) qualitativ | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | optional FISH | PDGFRA (4q12) | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | optional FISH | PDGFRB (5q33) | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | optional FISH | FGFR1 (8p11) | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | optional FISH | CEP9 (Zentromer 9) | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | molecular genetics | BCR/ABL quantitativ* | - |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | molecular genetics | JAK2-V617F | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | molecular genetics | JAK2-Exon12 bei PV | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | molecular genetics | MPLW515L/K-Mutation bei ET/PMF | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | molecular genetics | CALR | + |
| Tumor cytogenetics | Myeloproliferative neoplasm (MPN) | NGS | MPN-Panel (ABL1; ASXL1; CALR; CBL; CSF3R; EZH2; IDH1; IDH2; JAK2; KIT; MPL; SETBP1; SF3B1; SRSF2; TET2; U2AF1) | - |
| Tumor cytogenetics | Lymphomas | chromosome banding analysis | - | + |
| Tumor cytogenetics | Lymphomas | optional FISH | ALK (2p23) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | BCL6 (3q27) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | MYC (8q24) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | IGH (14q32) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | CCND1/IGH t(11;14) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | BIRC3/ MALT1 t(11;18) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | IGH/BCL2 t(14;18) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | TRA/D (14q11.2) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | BCL2 (18q12) | + |
| Tumor cytogenetics | Lymphomas | optional FISH | TP53 (17p13) | + |
| Tumor cytogenetics | Non-small-cell lung carcinom (NSCLC) | FISH | ALK (2p23) | + |
| Tumor cytogenetics | Non-small-cell lung carcinom (NSCLC) | FISH | ROS1 (6q22.1) | + |
| Tumor cytogenetics | Non-small-cell lung carcinom (NSCLC) | FISH | C-MET (7q31) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | chromosome banding analysis | - | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | FISH | CDKN2C/CKS1B (1p32/1q21) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | FISH | CCND1/IGH t(11;14) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | FISH | RB1 (13q14.1-14.3)/ D13S25 (13q14.3) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | FISH | IGH (14q32) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | FISH | TP53 (17p13) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | optional FISH | FGFR3/IGH t(4;14) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | optional FISH | IGH/MAF t(14;16) | + |
| Tumor cytogenetics | Plasma cell neoplasm (MM, PCL, MGUS) | optional FISH | IGH/MAFB t(14;20) | + |
| Postnatal cytogenetics | Cri-du-Chat syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Cri-du-Chat syndrome | FISH | 5p15.2 | + |
| Postnatal cytogenetics | DiGeorge syndrome CATCH22 | chromosome banding analysis | - | + |
| Postnatal cytogenetics | DiGeorge syndrome CATCH22 | FISH | 22q11.2 | + |
| Postnatal cytogenetics | Down-Syndrome | optional FISH | 21q22 | + |
| Postnatal cytogenetics | Kallmann syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Kallmann syndrome | chromosome banding analysis | Xp22.3 | + |
| Postnatal cytogenetics | Klinefelter-Syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Klinefelter-Syndrome | optional FISH | X/Y | + |
| Postnatal cytogenetics | Klinefelter-Syndrome | optional FISH | SRY (Yp11.3) | + |
| Postnatal cytogenetics | Microdeletion syndrome 1p36 | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Microdeletion syndrome 1p36 | FISH | 1p36 | + |
| Postnatal cytogenetics | Miller-Dieker-Syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Miller-Dieker-Syndrome | chromosome banding analysis | 17p13 | + |
| Postnatal cytogenetics | Prader-Willi-/Angelman syndrom | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Prader-Willi-/Angelman syndrom | FISH | 15q11-13 | + |
| Postnatal cytogenetics | Smith-Magenis syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Smith-Magenis syndrome | FISH | 17p13.3 | + |
| Postnatal cytogenetics | subtelomer screening | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Turner-Syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Turner-Syndrome | optional FISH | X/Y | + |
| Postnatal cytogenetics | Turner-Syndrome | optional FISH | SHOX | + |
| Postnatal cytogenetics | Williams-Beuren syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Williams-Beuren syndrome | FISH | 7q11.23 | + |
| Postnatal cytogenetics | Wolf-Hirschhorn syndrome | chromosome banding analysis | - | + |
| Postnatal cytogenetics | Wolf-Hirschhorn syndrome | FISH | 4p16.3 | + |
| Prenatal cytogenetics | suspicious ultrasound result | chromosome banding analysis | - | + |
| Prenatal cytogenetics | suspected syndrome | FISH | Aneuploidien der Chromosomen 13; 18; 21; X u. Y | + |
| Prenatal cytogenetics | maternal age | Analysis of AChE* | - | - |
| Prenatal cytogenetics | maternal age | Analysis of AFP* | - | - |